Addex Therapeutics Ltd (SWX:ADXN)
Switzerland · Delayed Price · Currency is CHF 0.0650
+0.0046 (7.62%)
Sep 30, 2025, 5:31 PM CET
Addex Therapeutics Market Cap
Addex Therapeutics has a market cap or net worth of 5.94 million as of September 30, 2025. Its market cap has decreased by -20.91% in one year.
Market Cap
5.94M
Enterprise Value
3.15M
Revenue
167.29K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since May 22, 2007, Addex Therapeutics's market cap has decreased from 398.65M to 5.94M, a decrease of -98.51%. That is a compound annual growth rate of -20.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2025 | 6.39M | 13.66% |
| Dec 30, 2024 | 5.62M | -9.01% |
| Dec 29, 2023 | 6.18M | -40.48% |
| Dec 30, 2022 | 10.39M | -73.65% |
| Dec 30, 2021 | 39.42M | -25.96% |
| Dec 30, 2020 | 53.24M | 22.57% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 219.71B |
| Novartis AG | 191.75B |
| Lonza Group AG | 36.51B |
| Galderma Group AG | 32.36B |
| Alcon | 29.19B |
| Sandoz Group AG | 20.46B |
| Straumann Holding AG | 13.91B |
| Sonova Holding AG | 13.17B |